A simple assay for inhibitors of mycobacterial oxidative phosphorylation
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Abstract Oxidative phosphorylation, the combined activities of the electron transport chain (ETC) and adenosine triphosphate (ATP) synthase, has emerged as a valuable target for antibiotics to treat infection with Mycobacterium tuberculosis and related pathogens. In oxidative phosphorylation, the ETC establishes a transmembrane electrochemical proton gradient that powers ATP synthesis. Monitoring oxidative phosphorylation with luciferase-based detection of ATP synthesis or measurement of oxygen consumption can be technically challenging and expensive. These limitations reduce the utility of these methods for characterization of mycobacterial oxidative phosphorylation inhibitors. Here we show that fluorescence-based measurement of acidification of inverted membrane vesicles (IMVs) can detect and distinguish between inhibition of the ETC, inhibition of ATP synthase, and non-specific membrane uncoupling. In this assay, IMVs from M. smegmatis are acidified either through the activity of the ETC or ATP synthase, the latter modified genetically to allow it to serve as an ATP-driven proton pump. Acidification is monitored by fluorescence from 9-amino-6-chloro-2-methoxyacridine, which accumulates and quenches in acidified IMVs. Non-specific membrane uncouplers prevent both succinate- and ATP-driven IMV acidification. In contrast, the ETC Complex III 2 IV 2 inhibitor telacebec (Q203) prevents succinate-driven acidification but not ATP-driven acidification and the ATP synthase inhibitor bedaquiline prevents ATP-driven acidification but not succinate-driven acidification. We use the assay to show that, as proposed previously, lansoprazole sulfide is an inhibitor of Complex III 2 IV 2 while thioridazine uncouples the mycobacterial membrane non-specifically. Overall, the assay is simple, low cost, and scalable, which will make it useful for identifying and characterizing new mycobacterial oxidative phosphorylation inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 2×
“Bedaquiline inhibits mycobacterial ATP synthase by binding with low af fi nity to the ring of c subunits in the enzyme ’ s rotor subcomplex (14, 15), with two high-af fi nity binding sites at the interface of subunit a with the c ring (16).”
BackgroundWayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141 · cited 1×
“Although mycobacteria can use electrons from menaquinol to reduce nitrate, fumarate, and hydrogen (7), oxygen is essential for mycobacterial growth (8, 9).”
BackgroundNonreplicating Persistence of Mycobacterium Tuberculosis
Wayne, L. G., & Sohaskey, C. D. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.139 · Cited by 807 · cited 1×
“Although mycobacteria can use electrons from menaquinol to reduce nitrate, fumarate, and hydrogen (7), oxygen is essential for mycobacterial growth (8, 9).”
BackgroundDiarylquinolines target subunit c of mycobacterial ATP synthase
Koul, A., Dendouga, N., Vergauwen, K., Molenberghs, B., Vranckx, L., Willebrords, R., Ristic, Z., Lill, H., Dorange, I., Guillemont, J., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio884 · Cited by 547
Fumarate Reductase Activity Maintains an Energized Membrane in Anaerobic Mycobacterium tuberculosis
Watanabe, S., Zimmermann, M., Goodwin, M. B., Sauer, U., Barry, C. E., & Boshoff, H. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002287 · Cited by 246 · cited 1×
“Two forms of respiratory Complex II (Sdh1 and Sdh2), and possibly fumarate reductase functioning in reverse (3), serve as succinate:quinone oxidoreductases.”
BackgroundUnique Flexibility in Energy Metabolism Allows Mycobacteria to Combat Starvation and Hypoxia
Berney, M., & Cook, G. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008614 · Cited by 235 · cited 12×
“NADH is oxidized by at least two different NADH dehydrogenases: the proton pumping respiratory Complex I as well as one or more nonproton pumping NDH-2 enzymes.”
BackgroundInfluentialEnergetics of Respiration and Oxidative Phosphorylation in Mycobacteria
Cook, G. M., Hards, K., Vilchèze, C., Hartman, T., & Berney, M. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0015-2013 · Cited by 212 · cited 2×
“There are many remaining fundamental questions about mycobacterial oxidative phosphorylation and how it adapts to different growth conditions (5, 7, 46).”
BackgroundYano, T., Li, L.-S., Weinstein, E., Teh, J.-S., & Rubin, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508844200 · Cited by 150 · cited 11×
“The assay also shows that thioridazine (THZ), a first generation antipsychotic drug that was found to inhibit mycobacterial NDH-2 (Rao et al., 2008; Weinstein et al., 2005; Yano et al., 2006), functions as an uncoupler of the PMF at micromolar concentrations.”
BackgroundInfluentialMatsoso, L. G., Kana, B. D., Crellin, P. K., Lea-Smith, D. J., Pelosi, A., Powell, D., Dawes, S. S., Rubin, H., Coppel, R. L., & Mizrahi, V. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.18.6300-6308.2005 · Cited by 134 · cited 1×
“CIII 2 CIV 2 activity can be replaced, at least in part, by cytochrome bd (20, 21), and although treatment of M. tuberculosis-infected marmosets with a telacebec analog controlled disease progression and reduced lesion-associated in fl ammation, it led to most lesions becoming cavitary (22).”
Background
Cited by
High-resolution electron cryomicroscopy of V-ATPase in native synaptic vesicles
Coupland, C. E., Karimi, R., Bueler, S. A., Liang, Y., Courbon, G. M., Di Trani, J. M., Wong, C. J., Saghian, R., Youn, J.-Y., Wang, L.-Y., et al. (2024) · Science · doi:10.1126/science.adp5577 · Cited by 58
Self-citationDi Trani, J. M., Yu, J., Courbon, G. M., Lobez Rodriguez, A. P., Cheung, C.-Y., Liang, Y., Coupland, C. E., Bueler, S. A., Cook, G. M., Brzezinski, P., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2423761122 · Cited by 16
Self-citationStructure of Mycobacterial NDH-2 Bound to a 2-Mercapto-Quinazolinone Inhibitor
Liang, Y., Bueler, S. A., Cook, G. M., & Rubinstein, J. L. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00049 · Cited by 13
Self-citationStructural basis for EtfD-mediated coupling of β-oxidation and the respiratory chain in mycobacteria
Courbon, G. M., Makarov, V., Cole, S. T., Schnapinger, D., Ehrt, S., & Rubinstein, J. L. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00726-y · Cited by 1
Self-citation
Metadata
- Authors
- Harden, S. A., Courbon, G. M., Liang, Y., Kim, A. S., & Rubinstein, J. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2024-01
- Volume
- 300
- Issue
- 1
- Pages
- 105483
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W4388818642
- Cited by
- 14
- References
- 9
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A simple assay for inhibitors of mycobacterial oxidative phosphorylation. https://app.cochat.ai/papers/10.1016/j.jbc.2023.105483
- The paper
- Harden, S. A., Courbon, G. M., Liang, Y., Kim, A. S., & Rubinstein, J. L. (2024). A simple assay for inhibitors of mycobacterial oxidative phosphorylation. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105483
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.